Search Results

There are 46099 results for: content related to: Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

  1. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. You have free access to this content
    Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 1018–1027, Y. ROTMAN, B. B. BORG, A. SOZA, J. J. FELD, A. A. MODI, R. LOOMBA, G. LUTCHMAN, E. RIVERA, E. DOO, M. G. GHANY, T. HELLER, A. U. NEUMANN, T. J. LIANG and J. H. HOOFNAGLE

    Version of Record online : 16 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04263.x

  3. Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e154–e162, J.-C. Cheng, Y.-J. Yeh, Y.-H. Huang, K.-H. Liang, M.-L. Chang, C.-Y. Lin and C.-T. Yeh

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1365-2893.2011.01538.x

  4. You have free access to this content
    Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1400–1401, Qiuwei Pan, Hugo W. Tilanus, Harry L.A. Janssen and Luc J. W. van der Laan

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24202

  5. You have free access to this content
    Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop

    Hepatology

    Volume 47, Issue 1, January 2008, Pages: 306–320, Raymond T. Chung, Michael Gale Jr, Stephen J. Polyak, Stanley M. Lemon, T. Jake Liang and Jay H. Hoofnagle

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22070

  6. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  7. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  8. You have free access to this content
    Reply:

    Hepatology

    Volume 53, Issue 4, April 2011, Page: 1400, Maria Stepanova and Zobair M. Younossi

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24210

  9. You have free access to this content
    Correspondence

    Hepatology

    Volume 53, Issue 4, April 2011, Page: 1403, Mindie Nguyen and Khoa Lam

    Version of Record online : 11 MAR 2011, DOI: 10.1002/hep.24225

  10. You have free access to this content
    Reply:

    Hepatology

    Volume 53, Issue 4, April 2011, Page: 1407, Tahany Awad, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk and Christian Gluud

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24236

  11. You have free access to this content
    Hepatitis C recurrence: Influence of serum cholesterol levels and liver steatosis on antiviral therapy

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1409–1410, Gianni Testino and Paolo Borro

    Version of Record online : 28 DEC 2010, DOI: 10.1002/hep.24034

  12. An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis B

    Liver International

    Volume 35, Issue 7, July 2015, Pages: 1824–1832, Louis Jansen, Annikki de Niet, Zuzanna Makowska, Michael T. Dill, Karel A. van Dort, Valeska Terpstra, R. Bart Takkenberg, Harry L.A. Janssen, Markus H. Heim, Neeltje A. Kootstra and Hendrik W. Reesink

    Version of Record online : 21 JAN 2015, DOI: 10.1111/liv.12768

  13. You have free access to this content
    Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1411–1412, Mevlut Kurt

    Version of Record online : 10 JAN 2011, DOI: 10.1002/hep.24051

  14. You have free access to this content
    Warning: Genome-wide association studies can be misleading. An example in hepatology

    Hepatology

    Volume 53, Issue 4, April 2011, Page: 1408, Pierre Galichon, Alexandre Hertig, Eric Rondeau and Laurent Mesnard

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24198

  15. You have free access to this content
    Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 Haplotype

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1410–1411, Matthew L. Albert, Armanda Casrouge, Stéphane Chevaliez, Christophe Hézode, Isabelle Rosa, Philippe Renard, Vincent Mallet, Arnaud Fontanet, Jean-Michel Pawlotsky and Stanislas Pol

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24055

  16. You have free access to this content
    Poster Session 2: HCV Virology and Pathogenesis

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 690A–713A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28220

  17. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  18. Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e1–e10, C. Xiao, B. Qin, L. Chen, H. Liu, Y. Zhu and X. Lu

    Version of Record online : 23 OCT 2011, DOI: 10.1111/j.1365-2893.2011.01471.x

  19. You have free access to this content
    The importance of the definition of early virological response for predicting treatment efficacy for chronic hepatitis C

    Hepatology

    Volume 53, Issue 4, April 2011, Page: 1403, Ming-Lung Yu

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24117

  20. You have free access to this content
    Insurance status and treatment candidacy of patients with hepatitis C: Taiwanese patients are luckier

    Hepatology

    Volume 53, Issue 4, April 2011, Page: 1399, Chia-Yen Dai, Ming-Lun Yeh, Jee-Fu Huang, Wan-Long Chuang and Ming-Lung Yu

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24197